Summary. Plasma immunoreactive secretin and insulin concentrations were measured in fasting normal humans after intraduodenal infusions of hydrochloric acid, isotonic or hypertonic glucose. The effect of intraduodenal acidification or intravenous bolus injections of secretin on plasma insulin concentrations during infusions of glucose was also examined. The intraduodenal glucose load did not cause an increase in plasma secretin concentrations. Secretin concentrations rose after acid both in the fasting state and during infusions of glucose. A concomitant rise in insulin levels was however only observed during infusions of glucose. Intravenous injection of secretin in a dose which mimicked the response to intraduodenal acidification was without effect on the glucose-stimulated insulin release, while a 30 times higher dose caused a highly significant augmentation of the insulin release. The insulin response pattern to this high dose of secretin differed completely from that observed after intraduodenal infusion of acid. It is concluded and confirmed that the stimulating effect of secretin on insulin secretion is pharmacological and that secretin plays no significant role in the entero-insular axis.
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Intrajejunal administration of glucose results in a considerably greater rise in serum insulin concentrations than intravenous administration of glucose at the same rate [1] . This difference in insulin response has been attributed to the operation of an enteroinsular axis entailing enhanced release of insulin by gastrointestinal hormones [2] . Concerning the action of secretin on insulin secretion, stimulation [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] as well as no effect [17] [18] [19] [20] [21] have been reported.
Criteria by which the role of a substance in the entero-insular axis is established must include demonstration of a release of the substance by oral secretagogues which normally release insulin (notably glucose), and demonstration that intravenous administration of a pure preparation of the substance in doses mimicking its physiological release, will augment the insulin response to elevated blood glucose.
Having established a sensitive and reliable radioimmunoassay for secretin we decided to reinvestigate the effect of endogenous and exogenous secretin on basal-and glucose-stimulated insulin secretion in man. Taking advantage of the measurements of secretin we were able to clarify if secretin played any physiological role.
Material and Methods

Sub/ects and Experimental Procedures
Seven healthy normal weight subjects (3 male: 4 female) all members of the paramedical staff volunteered for the study after the nature, purpose and possible risks had been carefully explained to them. Ages ranged from 19 to 36 years (mean, 28 years). Subjects were on a diet containing at least 250 g carbobydrates per day for 3 days before each investigation. Each subject was examined on seven different occasions at intervals of not less than 5 days. The experiments were performed in randomized order after an overnight fast. Intraduodenal infusion of test substances was accomplished via a nasoduodenal polyethylene tube positioned under fluoroscopic control with the tube opening into the second part of the duodenum. The position of the tube was confirmed 0012-186X/78/0014/0229/$01.20 Intraduodenal Acidification in the Basal State. Forty ml HC1 0.1 tool/1 (made isotonic with NaC1) was infused into the duodenum of each subject over a period of 3 rain. Blood samples were withdrawn at 20, 10 and 0 rain before and 5, 10, I5, 20, 30, 45 and 60 rain after the onset of the infusion.
Intraduodenal Glucose Loading. Intraduodenal infu-
sions of 40 ml of isotonic glucose (0.3 mol/1) or 40 ml hypertonic glucose (1.4 moll1) were accomplished using the same protocol as for HC1. The glucose solutions were adjusted to pH 7.0 with NaOH 0.15 mol/1.
Intraduodenal Infusion of Saline. In these control
experiments an identical volume of isotonic NaCI was infused instead of HC1 and glucose. Intravenous Injections of Secretin. Thirty min after the onset of the above mentioned intravenous glucose infusion, secretin (pure natural porcine secretin, GIH Research Laboratory, Karolinska Institutet, Stockholm, Sweden) was injected intravenously in the course of a few seconds. Two doses were used: 1) a small dose of 0.5 pmol/kg body weight, which mimicked the secretin response to intraduodenal acidification and 2) a large dose of 16 pmol/kg. The calculated dose of secretin was dissolved in 5 ml isotonic NaC1. Blood samples were withdrawn at 20, 10 and 0 rain before and at 1, 2, 3, 4, 5, 10, 15 and 20 min after the secretin injections.
Laboratory Analysis
Plasma secretin concentration was measured radioimmunochemically [22] using antibody 5595-3 raised to synthetic porcine secretin [23] . Synthetic secretin (kindly donated by Prof. E. Wiinsch, MaxPlanck-Institut, Munich, GFR) was iodinated by a chloramine T method to a specific radioactivity of approximately 400 ~tCi/nmol [24] . Pure natural porcine secretin (GIH Research Laboratory, Karolinska Institutet, Stockholm, Sweden) was used as standard and separation of free from antibody-bound labelled secretin was carried out using plasma-coated charcoal. The lowest concentration of secretin in plasma to be distinguished from zero with 95 per cent confidence was 1.3 pmol/1. The within-assay coefficient of variation was 8.8 per cent and between-assay 9.7 per cent at a level of 22 pmol/1. All samples were assayed in triplicate. Insulin concentration was measured by a sensitive radioimmunoassay utilizing Wick-chromatography as separation method [25] . The detection limit of the assay was less than 7 pmol/1 (1 ~tU/ ml) and between-assay coefficient of variation 10 per cent at a level of 144 pmol/l (20 ~tU/ml). Plasma glucose was measured by a glucose-oxidase method on a Technicon Autoanalyzer [26] .
Intraduodenal Acidification during Intravenous Infusion of Glucose. A stable plasma glucose concentration of approximately 11 mmol/l was rapidly reached by giving an intravenous priming dose of glucose,
Statistical Analysis
Statistical analysis was performed using the Wilcoxon matched-pairs signed-ranks test and the Friedman two-way analysis of variance [27] . Differences resulting in P values of less than 0.05 were considered significant. Results are expressed as means _+ SEM.
Results
Effect of Intraduodenal Acidification in the Basal
State (Fig. 1) The infusion of HC1 resulted in a significant rise in plasma secretin concentration from 1.3 _4-0.4 pmol/1 to a peak value of 13.0 + 1.2 pmol/1 after 5 rain, which returned to the fasting level within 15 rain. Plasma insulin and plasma glucose concentrations were unaffected. (Fig. 2) After intraduodenal infusion of isotonic or hypertonic glucose no significant changes in plasma secretin concentration were observed. Ten min after the infusion of isotonic glucose the peak values in plasma glucose and plasma insulin concentrations were achieved, being 5. 
Effect of lntraduodenal Glucose Loading
Response to Intraduodenal Infusion of Saline
No significant changes in plasma secretin, plasma insulin or plasma glucose concentrations were observed. (Fig. 3) Intravenous infusion of glucose resulted in plateau glucose and insulin concentrations averaging 11 mmol/1 and 200 pmol/1 (28 ~tU/ml), respectively. The infusion of HC1 resulted in a significant increase in plasma secretin concentration from 1.4 _+ 0.5 pmol/l to a peak value of 12.8 + 2.8 pmol/1 after 5 min. A return to basal levels was reached within 15 rain. A significant increase in plasma insulin concentration was observed after 5 rain and by 30 rain after the intraduodenal acidification a maximum of 348 _+ 44 pmol/1 (48 + 6 ~tU/ml) was obtained. The concentration did not return to prestimulated value within the 60 min observation period. The rise in plasma insulin concentration was accompanied by a progressive and significant decrease in plasma glucose concentration. (Fig. 4) After bolus injection of secretin in a dose of 0.5 pmol/kg, plasma secretin concentration rose from 1.4 +_ 0.3 pmol/1 to a peak value of 6.8 + 0.9 pmol/1 after 2 min and returned to the prestimulated level within 10 rain. No significant changes in plasma insulin or plasma glucose concentrations were observed. Injection of secretin in a dose of 16 pmol/kg resulted in a peak value in plasma secretin concentration of 352 + 52 pmol/1 after 2 min. This high dose of secretin was followed by a highly significant increase in plasma insulin concentration to a peak of 1417 + 199 pmol/1 (197 + 28 ~U/ml) after 4 min which returned to prestimulated values within 20 min. In accordance with the insulin release a significant decrease in plasma glucose concentration to 8.2 + 0.7 mmol/1 occurred.
Effect of Intraduodenal Acidification on GlucoseStimulated Insulin Secretion
Effect of Exogenous Secretin on Glucose-Stimulated Insulin Secretion
Discussion
The present study has not provided evidence that secretin is a candidate in the entero-insular axis, since intraduodenal glucose loading did not cause the release of secretin and since exogenous secretin given intravenously in a dose which mimicked the secretin response to intraduodenal acidification was without effect on glucose-stimulated insulin secretion. The lack of an increase in the plasma concentration of immunoreactive secretin after intraduodenal glucose administration is in accordance with results observed in anaesthetized dogs [28] and pigs [29] . As reported by O'Connor et al. [21] intraduodenal acidification was without effect on plasma insulin concentration in fasting man. During hyperglycaemia, however, the infusion of hydrochloric acid into the duodenum was associated with a long-lived augmentation of the insulin response (Fig. 3) . This insulin response pattern differed completely from that observed after intravenous injection of a large dose of secretin (Fig. 4B) and thus other substances must be involved. Secretin is not the only gastrointestinal peptide which is released by intestinal acidification. Thus vasoactive intestinal polypeptide [30] and cholecystokinin [31] are both released. These peptides are both known to have an insulinogenic action [32] and might be responsible for the observed augmentation in the insulin response after intraduodenal infusion of hydrochloric acid. Gastric inhibitory polypeptide (GIP), which for the time being is considered to be the most important hormone in the entero-insular axis, is however not released by intestinal acidification (Lauritsen and Moody, personal communication).
During normal physiological conditions secretin is released in short-lived spikes resulting in concentrations in peripheral venous plasma which never exceed 10 pmol/1 [33] . Thus, only the small dose of secretin used in the present study can be considered to be within the physiological range. This dose was without effect on plasma insulin and plasma glucose concentrations. The finding is consistent with the recent results of Enk [16] , who in dose-response studies found that a secretin dose of 0.9 pmol/kg had no insulinogenic effect in normal subjects. The large dose of secretin used in this and in several previous studies was able to release biologically active insulin. This dose, however, results in plasma concentrations of secretin which are far above the upper limit of physiological range.
In conclusion, the stimulating effect of secretin on insulin secretion must be considered to be a pharmacological action and there is no evidence that secretin plays a significant role in the entero-insular axis under normal physiological conditions.
